Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer.

Autor: Nersesian S; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.; Department of Medicine, Dalhousie University, Halifax, NS, Canada., Glazebrook H; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada., Toulany J; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.; Department of Medicine, Dalhousie University, Halifax, NS, Canada., Grantham SR; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada., Boudreau JE; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.; Department of Pathology, Dalhousie University, Halifax, NS, Canada.

Publikováno v: Frontiers in immunology [Front Immunol] 2019 Aug 09; Vol. 10, pp. 1782. Date of Electronic Publication: 2019 Aug 09 (Print Publication: 2019).

Jadomycins Inhibit Type II Topoisomerases and Promote DNA Damage and Apoptosis in Multidrug-Resistant Triple-Negative Breast Cancer Cells.

Autor: Hall SR; Department of Pharmacology, Faculty of Medicine (S.R.H., K.B.G.), College of Pharmacy, Faculty of Health (J.T., L.G.B, D.L.J., K.B.G.), and Department of Chemistry, Faculty of Sciences (C.F.M.-F., A.W.R., D.L.J.), Dalhousie University, Halifax, Nova Scotia, Canada., Toulany J; Department of Pharmacology, Faculty of Medicine (S.R.H., K.B.G.), College of Pharmacy, Faculty of Health (J.T., L.G.B, D.L.J., K.B.G.), and Department of Chemistry, Faculty of Sciences (C.F.M.-F., A.W.R., D.L.J.), Dalhousie University, Halifax, Nova Scotia, Canada., Bennett LG; Department of Pharmacology, Faculty of Medicine (S.R.H., K.B.G.), College of Pharmacy, Faculty of Health (J.T., L.G.B, D.L.J., K.B.G.), and Department of Chemistry, Faculty of Sciences (C.F.M.-F., A.W.R., D.L.J.), Dalhousie University, Halifax, Nova Scotia, Canada., Martinez-Farina CF; Department of Pharmacology, Faculty of Medicine (S.R.H., K.B.G.), College of Pharmacy, Faculty of Health (J.T., L.G.B, D.L.J., K.B.G.), and Department of Chemistry, Faculty of Sciences (C.F.M.-F., A.W.R., D.L.J.), Dalhousie University, Halifax, Nova Scotia, Canada., Robertson AW; Department of Pharmacology, Faculty of Medicine (S.R.H., K.B.G.), College of Pharmacy, Faculty of Health (J.T., L.G.B, D.L.J., K.B.G.), and Department of Chemistry, Faculty of Sciences (C.F.M.-F., A.W.R., D.L.J.), Dalhousie University, Halifax, Nova Scotia, Canada., Jakeman DL; Department of Pharmacology, Faculty of Medicine (S.R.H., K.B.G.), College of Pharmacy, Faculty of Health (J.T., L.G.B, D.L.J., K.B.G.), and Department of Chemistry, Faculty of Sciences (C.F.M.-F., A.W.R., D.L.J.), Dalhousie University, Halifax, Nova Scotia, Canada., Goralski KB; Department of Pharmacology, Faculty of Medicine (S.R.H., K.B.G.), College of Pharmacy, Faculty of Health (J.T., L.G.B, D.L.J., K.B.G.), and Department of Chemistry, Faculty of Sciences (C.F.M.-F., A.W.R., D.L.J.), Dalhousie University, Halifax, Nova Scotia, Canada kerry.goralski@dal.ca.

Publikováno v: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2017 Nov; Vol. 363 (2), pp. 196-210. Date of Electronic Publication: 2017 Sep 13.

CMKLR1 activation ex vivo does not increase proportionally to serum total chemerin in obese humans.

Autor: Toulany J; College of PharmacyDalhousie University, Halifax, Nova Scotia, Canada., Parlee SD; Department of Molecular & Integrative PhysiologyUniversity of Michigan, Ann Arbor, Michigan, USA., Sinal CJ; Department of PharmacologyDalhousie University, Halifax, Nova Scotia, Canada., Slayter K; Canadian Centre for VaccinologyIWK Health Centre, Nova Scotia Health Authority and Dalhousie University, Halifax, Nova Scotia, Canada., McNeil S; Canadian Centre for VaccinologyIWK Health Centre, Nova Scotia Health Authority and Dalhousie University, Halifax, Nova Scotia, Canada., Goralski KB; College of PharmacyDalhousie University, Halifax, Nova Scotia, Canada kerry.goralski@dal.ca.; Department of PharmacologyDalhousie University, Halifax, Nova Scotia, Canada.

Publikováno v: Endocrine connections [Endocr Connect] 2016 Nov; Vol. 5 (6), pp. 70-81. Date of Electronic Publication: 2016 Nov 08.

Identification of STEAP3-based molecular subtype and risk model in ovarian cancer.

Autor: Zhao, Zouyu^1,2 (AUTHOR), Sun, Chongfeng^1,2 (AUTHOR), Hou, Jishuai^1,2 (AUTHOR), Yu, Panpan^1,2 (AUTHOR), Wei, Yan¹ (AUTHOR), Bai, Rui¹ (AUTHOR), Yang, Ping^1,2 (AUTHOR) pingy2018@163.com

Publikováno v: Journal of Ovarian Research. 6/29/2023, Vol. 16 Issue 1, p1-15. 15p.

Inflammation, immune cells, and cellular senescence in the aging ovary.

Autor: Isola, José V. V., Hense, Jessica D., Osório, César A. P., Biswas, Subhasri, Alberola-Ila, José, Ocañas, Sarah R., Schneider, Augusto, Stout, Michael B.

Publikováno v: Reproduction; Aug2024, Vol. 168 Issue 2, p1-14, 14p